Robert C. Moscato, Jr

Overview

Robert C. Moscato, Jr received $436K in total compensation, including $191K in salary, at Marina Biotech in 2018. Robert Moscato also received an average of $148K at Avalo Therapeutics between 2017 and 2018.

Source: SEC filings on November 19, 2019, June 19, 2019, and April 5, 2018.

Related executives

We found 24 more executives who work or worked at Marina Biotech and Avalo Therapeutics.

Garry Neil

Avalo Therapeutics

Chief Executive Officer

Stephen Smolinski

Avalo Therapeutics

Former Chief Commercial Officer

Michael Cola

Avalo Therapeutics

Chief Executive Officer

Christopher Sullivan

Avalo Therapeutics

Chief Financial Officer

Schond Greenway

Avalo Therapeutics

Chief Financial Officer

H Wilkins

Avalo Therapeutics

Chief Medical Officer

Simon Pedder

Avalo Therapeutics

Chairman

Pericles Calias

Avalo Therapeutics

Chief Scientific Officer

News

You may also like